Coissac Patrice 4
4 · ALEXION PHARMACEUTICALS INC · Filed Aug 29, 2012
Insider Transaction Report
Form 4
Coissac Patrice
GM/President ALXN SAS Europe
Transactions
- Exercise/Conversion
Option to Purchase Common Stock
2012-08-27−12,198→ 77,802 totalExercise: $42.66From: 2011-05-02Exp: 2021-02-02→ Common Stock, par value $.0001 per share (12,198 underlying) - Exercise/Conversion
Option to Purchase Common Stock
2012-08-28−21,551→ 56,251 totalExercise: $42.66From: 2011-05-02Exp: 2021-02-02→ Common Stock, par value $.0001 per share (21,551 underlying) - Exercise/Conversion
Common Stock, par value $.0001 per share
2012-08-27$42.66/sh+12,198$520,367→ 127,814 total - Sale
Common Stock, par value $.0001 per share
2012-08-27$107.05/sh−41,932$4,488,821→ 85,882 total - Exercise/Conversion
Common Stock, par value $.0001 per share
2012-08-28$42.66/sh+21,551$919,366→ 107,433 total - Sale
Common Stock, par value $.0001 per share
2012-08-28$106.37/sh−21,551$2,292,380→ 85,882 total - Exercise/Conversion
Common Stock, par value $.0001 per share
2012-08-27$22.90/sh+29,734$680,909→ 115,616 total - Exercise/Conversion
Option to Purchase Common Stock
2012-08-27−29,734→ 37,500 totalExercise: $22.90From: 2010-04-28Exp: 2020-01-28→ Common Stock, par value $.0001 per share (29,734 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $107.00 - $107.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $106.00 - $106.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.